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Summary.-The immunogenicity of a soluble fraction containing Gross-virus-
associated cell-surface antigen (GCSAa) obtained from (C58NT)D lymphoma cells
either by detergent (NP40) solubilization or by 3M KCI extraction, was studied in
syngeneic W/Fu rats. Rats immunized by 2 s.c. injections of soluble antigen or
soluble antigen mixed with empty liposomes and emulsified in complete Freund's
adjuvant (CFA) failed to produce significant levels of cytotoxic antibodies to GCSAa.
On the other hand, rats similarly immunized by negatively charged liposomes con-
taining NP40-solubilized GCSAa, and emulsified in CFA, developed high and per-
sistent levels of cytotoxic antibodies, and their response could even mimic that
induced by viable (C58NT)D cells. A similar response could also be obtained in rats
immunized with liposome-associated NP40-solubilized GCSAa, but without CFA.
Rats immunized by comparable amounts of liposome-associated 3M KC1 -extracted
GCSAa developed only low levels of cytotoxic antibodies, and their response was of
shorter duration. These results strongly suggest that inclusion into liposomes of a
solubilized proteic tumour-associated cell-surface antigen can provide an immuno-
gen as potent as viable tumour cells in inducing an antibody response, and that the
solubilization method may be critical.
WE HAVE DESCRIBED (Sakal et al.,
1980) immunochemical characters of the
association with liposomes of Gross cell-
surface antigen (GCSAa), a major
cell-surface antigen, of proteic nature
(Ledbetter & Nowinski, 1977; Snyder
et al., 1977) associated with Gross
virus-induced lymphomas in the mouse
(Old et al., 1965) and rat (Geering
et al., 1966; Herberman, 1972) which
appears to play an important role in host-
tumour relationship and can induce high
antibody response in syngeneic rats (Ger-
lier et al., 1977a; Herberman & Oren,
1971). The present work describes the
antibody response elicited in syngeneic
W/Fu rats by immunization with lipo-
some-associated partly purified GCSAa,
and the results suggest that liposomal
presentation of this antigen can induce
cytotoxic antibodies to GCSAa, reaching
in some instances the level obtained after
immunization with viable syngeneic tu-
mour cells.
MATERIAL AND METHODS
Animals and tumour.-W/Fu/Rholco rats
and C57BL/6/Rholco mice were bred in our
colony. Five-weeks-old male W/Fu rats were
used for immunization. Gross-virus-induced
(C58NT) D lymphoma (Geering et al., 1966)
was maintained in ascitic form by weekly
passage into syngeneic weanling W/Fu rats.
Gross-virus-induced EdG2 lymphoma (Old
et al., 1965) was also weekly transplanted into
syngeneic C57BL/mice.
Antigen preparation.-Gross cell-surface
antigen (GCSAa) was extracted either by
Nonidet P40 (NP40) or 3M KCI from
(C58NT)D lymphoma cells and partially
purified after 60% ammonium sulphate pre-
cipitation and Sephadex G200 filtration.
Details are given in Sakal et al. (1980).ANTIBODY TO LIPOSOME-ASSOCIATED GCSAa
Liposomepreparation.-Negatively charged
liposomes were prepared as described by
Gregoriadis et al. (1971). Details of liposome
sensitization with GCSAa have been reported
elsewhere (Sakal et al., 1980). Briefly,
a film of dipalmitoylphosphatidylcholine,
cholesterol and dicetylphosphate in 7:2:1
molarratio, was dispersed in antigenic extract
obtained either by NP40 or by 3M KCI
solubilization. Liposomes used in these
experiments had a protein/phospholipid ratio
of 0.15-0-20, most GCSAa activity being
firmly associated with lipids (Sakal et al.,
1980) and were injected immediately without
previous storage. As control, empty liposomes
were similarly prepared by dispersion oflipids
in the buffer.
Immunizations.-Groups of W/Fu rats
were immunized by 2 s.c. injections given 5
weeks apart with GCSAa preparations. In
one set of experiments NP40-solubilized
GCSAa was used as immunogen, presented
either as soluble antigen, soluble antigen
mixed with empty liposomes, or GCSAa-
sensitized liposomes, and injected with or
without complete Freund adjuvant (CFA). In
a second set ofexperiments, thekinetics ofthe
antibody response was studied using groups
of 4 rats receiving either soluble or liposome-
associated NP40-solubilized GCSAa with or
without CFA, and, in a third set of experi-
ments, the kinetics of the antibody response
to 3M KCl-solubilized GCSAa was studied
under similar conditions. Doses of injected
antigen are detailed in the Table. As control,
a group of W/Fu rats was immunized by a
single s.c. injection of 2 x 108 syngeneic
(C58NT)D viable lymphoma cells, since
calculation based on the specific activity of
antigenic extract indicated that rats in the
other groups were immunized with a quantity
of GCSAa grossly amounting to the cell-
surface expression by 2 x 108 (C58NT)D
cells (Gerlier et al., 1977b). In all groups, a
blood sample was weekly collected from the
animals' tails.
Antibody production assay.-Sera from
animals under immunization were tested for
antibody to GCSAa, using a complement-
dependent cytotoxicity test as previously
described (Gerlier et al., 1977a). Briefly,
50 ,ul of E,G2 cell suspension (4 x 106 cells/
ml) was incubated for 45 min at 3700 with
50 ,ul of serial dilutions of serum and 50 ,ul
of an appropriate dilution of rabbit comple-
ment selected for absence of natural anti-
mouse activity. Percentage of dead cells was
determined by trypan-blue dye uptake.
Results are expressed as cytotoxic index (CI)
calculated as follows:
CI =
% dead cells in test- %/ dead cells in
control
100- % dead cells in control
and the endpoint titre was expressed as the
last serum dilution giving a C >0-5. Controls
of the specificity of GCSAa detection in this
cytotoxicitytest wereperformed byabsorbing
sera on mouse normal lymphoid cells, ESG2
lymphoma cells, or GCSAa- lymphoma cells
as previously described (Gerlier et al., 1977b).
TABLE.-Immunization of W/Fu rats with soluble or liposome-associated GCSAa
(C58NT)D
See Group cell GCSAa 1st
Fig. No. extract activity* injection
1 a NP40 16 0-69
b 0 44
c 044
d 0-61
2 a NP40 16-3 0 9
b 0-43
c 0-43
3 a 3MKCI 10-9 0-37
b 0.36
c 0-36
Immunizing material
r ( Proteins (mg) Phospholipids (mg)
Booster
0-52
0-25
0-25
054
0-56
0-37
0-37
0-52
0-52
0-52
1st
injection
0
2-43
2-43
(1-57)t
0
2-11
2-11
0
2-11
2-11
Booster
0
1-80
1 80
(2-32)t
0
2-39
2-39
0
2-90
2-90
* Results are expressed as jig protein absorbing 50% of the initial activity of 50 ,u anti-(C58NT)D serum
diluted 1:100 (Sakai et al., 1980).
t Empty liposomes.
17
Freund's
adjuvant
+
+
+
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RESULTS
Antibody response to NP40-solubilized
GCSAa
Injection ofliposome containing GCSAa
(0.44 mg and 0-25 mg protein) emulsified
with CFA induced an antibody response
3 weeks after the booster injection in
6/10 rats, the antibody response being
1:64 or more in 4 of these (Fig. 1). The
high cytotoxic-antibody titres in these
4 rats (1:64, 1:128, 1:256, 1:512) were
comparable to that in rats immunized
with viable cells, as previously described,
although immunization with tumour cells
usually elicits an antibody response in all
animals (Gerlier et at., 1977a). When rats
were immunized with the same GCSAa-
sensitized liposomes, but without CFA, or
with a higher amount of NP40-extracted
soluble GCSAa (0.69 mg and 0 52 mg
protein) emulsified in CFA, or with soluble
GCSAa (0-61 mg and 0 54 mg protein)
mixedwithempty liposomesandemulsified
in CFA (Fig. 1) all animals failed to
develop a significant antibody response.
Primary antibody response was also deter-
mined in every group of animals3-4 weeks
after the first injection and was always
of a low level in this set of experiments.
Antibody response to NP40-solubilized
GCSAa was further studied with the same
immunization schedule, to determine the
kinetics of this response, in comparison
with that of rats receiving viable tumour
cells. As observed in the preceding experi-
ment, injection of liposomes containing
GCSAa (0.43 mg and 0 37 mg protein)
emulsified with CFA induced a good
antibody response in 3/4 rats at the 8th
week (Fig. 2b) which reached in one rat
the same intensity as that produced by
immunization with viable tumour cells.
Low-level antibody responses were ob-
tained in rats immunized with soluble
antigen (0.9 mg and 0-56 mg protein)
emulsified with CFA (Fig. 2a) or with
some liposomes containing GCSAa but
without CFA (Fig. 2c) as previously
observed, with the exception of one rat
immunized with liposome containing
GCSAa without CFA (Fig. 2c) in which the
antibody response could parallel that
elicited by viable tumour cells. The
kinetics of antibody response induced by
liposome-associated GCSAa appeared to
be biphasic, in contrast to those of the
response induced by single or repeated
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FIG. 1. Secondary antibody responses in individual WV/Fu rats immunized with NP40-extracted
soluble or liposome-associated GCSAa. a, b, c, d refer to groups in Table: rats immunize(d with
(a) soluble antigen emulsified in CFA; (b) antigen-associated liposomes emulsified in CFA; (e)
antigen-associated liposomes -without CFA; (d) soluble antigen mixe(d with empty liposomes andl
emulsifie(d in CFA.
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FIG. 2. Kinetics of antibody production in
in(lividual W/Fu rats immunized witli
NP40-extracted soluble or liposome-asso-
ciated GCSAa. a, b, c refer to groups in
Table. See legend to Fig. 1. Dotted line
indicates the antibody response (geo-
metric mean titre) of rats immunized by a
single s.c. injection of 2 x 108 viable
(C58NT)D cells.
injection of viable tumour cells (Gerlier
et al., 1977a). Moreover, the secondary
peak of these antibody responses was
somewhat higher than the primary one
and persisted at a high level up to 13
weeks after the booster injection, similarly
to the viable tumour-cell-elicited antibody
response.
Antibody response to 3M KCI-solubilized
GCSAa
Similar immunization experiments were
performed with liposomes sensitized with
FIG. 3. Kinetics of antibody production in
individual W/Fu rats immunized with 3M
KCl-extracted soluble or liposome-asso-
ciated GCSAa. a, b, c refer to groups in
Table. See legend to Fig. 1. Dotted line
indicates the antibody response (geo-
metric mean titre) of rats immunized by a
single s.c. injection of 2 x 108 viable
(C58NT)D cells.
an equivalent amount of 3M KCl-solubil-
ized GCSAa, this cellular extract being of
similar in vitro specific activity to the
NP40 extract used in the above-reported
set of experiments. Immunization with
3M KCl-extracted soluble GCSAa (0.37
mg and 0-52 mg protein) emulsified with
CFA failed to induce a significant anti-
body response (Fig. 3a) as obtained with
NP40-solubilized antigen. Immunization
with liposome sensitized with 3M KCI-
solubilized GCSAa with or without CFA
(0.36 and 0-52 mg protein) induced only a
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moderate and transient antibody response
in the same animals (Fig. 3b, c).
DISCUSSION
In order to determine whether viable
tumour cells could be substituted by
soluble cell-surface antigen linked to
artificial membrane, in inducing an anti-
tumour response, we have previously
included GCSAa, a tumour-associated
virus-directed cell-surface antigen, into
negatively charged liposomes (Sakai et
al., 1980). The purpose of the present
work was to compare in syngeneic animals
the immunogenicity of soluble GCSAa
extracted from W/Fu (C58NT)D lym-
phoma by two currently used methods to
that of the liposome-associated antigen
and to that ofviable lymphoma cells.
While immunizations with viable lym-
phoma cells usually lead to a high and
persistent antibody response (Gerlier et
al., 1977a; Herberman & Oren, 1971)
immunizations with similar amounts of
solubilized GCSAa emulsified in CFA
induced only a weak antibody response
(out of 14 rats, 13 had an antibody titre
(AT) <1:8, 1 had AT=1:16). On the
other hand, immunization with liposomes
containing solubilized GCSAa and emulsi-
fied in CFA induces a significant antibody
response, which in some instances may be
as high and persistent as that induced by
immunization with live tumour cells
(AT) 1:64 in 7/14 rats) and GCSAa must
be presented as part ofliposome structure
to obtain this good antibody response,
since mixing soluble GCSAa with empty
liposomes elicits no antibody response
(AT,< 1:4 in 6/6 rats). However, the
antibody response of animals receiving
liposome-associated GCSAa is less homo-
geneous than that of the animals injected
with live tumour cells. This could be due
to a non-optimal immunization schedule,
since it has been previously demonstrated
that the achievement of a high and homo-
geneous antibody response to (C58NT)D
lymphoma cells depends upon the immu-
nization schedule (G(erlier et al., 1977a).
The antibody response of rats immunized
with liposomes sensitized with 3M KCI-
solubilized GCSAa was much lower in
magnitude and shorter in duration than
that of rats similarly immunized with
liposomes sensitized with NP40-solubilized
GCSAa. This could be attributed neither
to a difference in antigen dose, since the
in vitro specific GCSAa activities of both
types of cellular extract used in these
experiments were comparable, nor to a
difference in GCSAa association with
liposomes, since it has been shown in a
previous work that the liposome composi-
tion and the distribution of GCSAa among
liposomal structure are almost identical
whatever the sensitizing cellular extract
used (Sakai et al., 1980). Nevertheless,
it may be questioned whether the 2
different antigen-solubilization procedures
lead to GCSAa-bearing molecules of iden-
tical immunogenicity, since 3M KCI ex-
traction may induce proteolytic cleavage
(Mann, 1972) and since detergent solu-
bilization produces micellar association of
the solubilized molecules (Helenius &
Simons, 1975).
It can be questioned whether emulsify-
ing sensitized liposomes in CFA is a pre-
requisite for the induction of a high and
persistent antibody response to GCSAa,
since it has been reported (Nicolotti et al.,
1976) that antibody to liposome-associated
synthetic antigen can be raised only in the
presence of CFA. Microscopic examination
of the sensitized liposomes used in the
experiments reported here showed that, as
previously observed (Kinsky & Nicolotti,
1977) they remained intact when emulsi-
fied in CFA. From the present results it
appears that the use of CFA is not an
absolute prerequisite, since the antibody
response induced by liposome-associated
GCSAa without CFA could in some cases
(in 1/14 rats, AT > 1:64) parallel the
results using CFA. CFA emulsification
greatly increases the number ofresponding
animals (7/14 rats, AT,> 1]:64).
Thus it appears that liposome associa-
tion of GCSAa may produce an adjuvant
effect, which accords with previously
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reported effects of liposome presentation
ofvarious antigens (Allison & Gregoriadis,
1974; Heath et al., 1976) provided a phos-
pholipid of high transition temperature is
used to form the liposome (Dancey et al.,
1978; Yasuda et al., 1977) and this is
actually the case with dipalmitoylphos-
phatidycholine used in these experiments
(transition temperature: 41.5°C). It cannot
be excluded that the adjuvant effect
exerted by liposome association of the
antigen may be due to a membrane
presentation effect since it has been shown
that solubilized membrane antigen can
stimulate lymphocytes in vitro when
exposed on liposomes (Curman et al.,
1978; Engelhard et al., 1978). However
it is worth noting that the sensitized
liposome used here exposed only a small
proportion of the associated GCSAa at
their surface (Sakai et al., 1980).
In some of the responding animals
the antibody response persisted at a high
level for up to 18 weeks. This may be due
to a depot effect of the antigen associated
with liposomes made of high-transition-
temperature phospholipid, and which are
likely to be of poor fluidity at body tem-
perature. Further studies are necessary to
gain further insight into the mechanisms
involved in the adjuvant effect exerted by
liposomes in inducing cytotoxic antibodies
against cell-surface antigens. It is likely
that, for instance, efficient immunization
might require the presentation of tumour
cell-surface antigen in association with
the major histocompatibility complex
(MHC) antigens on the membrane. Either
of 2 mechanisms could fulfil this require-
ment: (1) liposome might be sensitized
with MHC antigens containing GCSAa;
(2) in the absence of MHC antigens in a
GCSAa preparation, this association might
be obtained as a result of an in vivo
fusion between liposomes and host cells.
So, it would be of the utmost interest to
study the interaction ofhost macrophages
(Yasuda et al., 1977) and lymphocytes
(Blumenthal et al., 1977; Ozato et al.,
1978) with liposome-associated solubilized
cell-surface antigen.
Resultsfrom the presentstudiesstrongly
suggest that, as far as antibody produc-
tion to cell-surface tumour-associated anti-
gen is concerned, liposome-associated solu-
bilized membrane proteins can substitute
viable tumour cells as immunogen, and
that the solubilization method used is
critical.
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